Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Meet Our Editorial Board Member:
Volume: 16 Issue: 2
Author(s): Heinz Wiendl
Affiliation:
Export Options
About this article
Cite this article as:
Wiendl Heinz, Meet Our Editorial Board Member:, Endocrine, Metabolic & Immune Disorders - Drug Targets 2016; 16 (2) . https://dx.doi.org/10.2174/187153031602160923151227
DOI https://dx.doi.org/10.2174/187153031602160923151227 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunomodulatory Actions of Vitamin D Metabolites and their Potential Relevance to Human Lung Disease
Current Respiratory Medicine Reviews Graphical Abstracts
Letters in Drug Design & Discovery Coupling Classical Analytical Methods with Modeling in Routine Analysis Tests - Merits and Drawbacks
Current Analytical Chemistry Plant Bioactive Peptides: Current Status and Prospects Towards Use on Human Health
Protein & Peptide Letters Do Statins Beneficially or Adversely Affect Glucose Homeostasis?
Current Vascular Pharmacology New Insights into the Pleiotropic Effects of Statins for Stroke Prevention
Mini-Reviews in Medicinal Chemistry The Real Impact of Target Therapy in Breast Cancer Patients: Between Hope and Reality
Current Cancer Drug Targets Primary Prevention of Cardiovascular Risk in Octogenarians by Risk Factors Control
Current Hypertension Reviews Phage Display Derived Therapeutic Antibodies
Current Pharmaceutical Biotechnology Targeting the Fatty Acid Transport Proteins (FATP) to Understand the Mechanisms Linking Fatty Acid Transport to Metabolism
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Immunotherapy and Cancer Vaccines in the Management of Breast Cancer
Current Pharmaceutical Design Osmotin, a Pathogenesis-Related Protein
Current Protein & Peptide Science Impact of Genetic Polymorphisms and Drug – Drug Interactions on Clopidogrel and Prasugrel Response Variability
Current Drug Metabolism NMDA Receptors in Glial Cells: Pending Questions
Current Neuropharmacology Development of Pin1 Inhibitors and their Potential as Therapeutic Agents
Current Medicinal Chemistry The Role of PPARs in Obesity and other Insulin Resistance Associated Disorders
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Pancreatic β-cell Glucose Toxicity in Type 2 Diabetes Mellitus
Current Diabetes Reviews Therapeutic Proteins for Treatment of Corneal Epithelial Defects
Current Medicinal Chemistry Enteric Ecosystem Disruption in Autism Spectrum Disorder: Can the Microbiota and Macrobiota be Restored?
Current Pharmaceutical Design Important Aspects of Post-Prandial Antidiabetic Drug, Acarbose
Current Topics in Medicinal Chemistry